SCHEMBL12313223

SCHEMBL12313223

Cc1cc(C)cc(-c2ccc3cc(-n4cccc4)ccc3n2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 11/20 0.52
▸ MAOB P27338 11/20 0.52
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ MAPT P10636 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ KLF5 Q13887 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12313221 0.90 MAOA (0.41) MAOAMAOBNPC1RAB9ACASP3
SCHEMBL3408047 0.89 MAOA (0.53) MAOAMAOBNPC1RAB9AKDM4E
SCHEMBL12313226 0.83 MAOA (0.50) MAOAMAOBNPC1RAB9ACASP3
SCHEMBL12313222 0.82 PDE10A (0.44) MAOAMAOBMAPTKDM4ESMN1; SMN2
SCHEMBL12313247 0.81 IGF1R (0.37) MAOAMAOBNPC1RAB9ACASP3
SCHEMBL12313220 0.80 MAOA (0.41) MAOAMAOBSMN1; SMN2POLBHPGD
SCHEMBL12313228 0.78 PDE10A (0.43) MAOAMAOBMAPTKDM4ESMN1; SMN2
SCHEMBL12313219 0.78 MAOA (0.42) MAOAMAOBNPC1RAB9ACASP3
SCHEMBL12313248 0.78 IGF1R (0.36) MAOAMAOBNPC1RAB9ACASP3
SCHEMBL12313237 0.78 IGF1R (0.36) MAOAMAOBNPC1RAB9ACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263237-B2 Red phosphorescent composition and organic electroluminescent device using the same LG DISPLAY CO., LTD (KR) 2012-09-11 — — US disclosed
US-8263237-B2 Red phosphorescent composition and organic electroluminescent device using the same LG DISPLAY CO., LTD (KR) 2012-09-11 — — US disclosed
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2010-04-29 — — US disclosed
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2010-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same YTHDC1, IK, PYCR1 MAOA 3569/4885MAOB 3019/4885NPC1 2402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback